| ATM | ataxia-telangiectasia mutated |
| ATR | ATM- and Rad3-related |
| AZT | azidothymidine |
| BA | benzoquinone ansamycin |
| BLM | bleomycin |
| CDK | cyclin-dependent kinase |
| CHK | checkpoint kinase |
| CIS | cytokine-induced senescence |
| DDR | DNA damage response |
| EGCG | (-)-epigallocatechin-3-gallate |
| GA | geldanamycin |
| GBM | glioblastoma; |
| GR | glucocorticoid receptor |
| HPMC | human peritoneal mesothelial cell |
| HSP90 | heat shock protein 90 |
| IFN | interferon |
| IFN-γ | interferon gamma |
| IR | ionizing radiation |
| NE | norepinephrine |
| NSCLC | non-small cell lung cancer |
| OIS | oncogene-induced senescence |
| Par-4 | prostate apoptosis response-4 |
| PARP | poly (ADP-ribose) polymerase |
| PLK | polo-like kinase |
| PT | pterostilbene |
| Rb | retinoblastoma |
| ROS | reactive oxygen species |
| RSV | resveratrol |
| SASP | senescence-associated secretory phenotype |
| TERT | telomerase reverse transcriptase |
| TIS | therapy-induced senescence |
| TMZ | temozolomide |
| TNF | tumor necrosis factor |
| TNKS | tankyrase |
| TNKS1 | tankyrase 1 |
| TNKS2 | tankyrase 2 |
| TRF1 | telomeric repeat binding factor 1 |
| TRF2 | telomeric repeat binding factor 2 |
| TSG | tumor suppressor gene |
| XRT | radiation therapy |
| ZDV | zidovudine |